| Primary |
| Schizophrenia |
21.4% |
| Product Used For Unknown Indication |
20.7% |
| Psychotic Disorder |
10.3% |
| Bipolar Disorder |
9.2% |
| Depression |
6.7% |
| Schizophrenia, Paranoid Type |
6.3% |
| Schizoaffective Disorder |
3.3% |
| Bipolar I Disorder |
2.7% |
| Anxiety |
2.4% |
| Mania |
2.4% |
| Agitation |
2.1% |
| Mental Disorder |
2.1% |
| Major Depression |
2.1% |
| Hypertension |
2.0% |
| Insomnia |
1.3% |
| Constipation |
1.1% |
| Schizophrenia, Catatonic Type |
1.1% |
| Affective Disorder |
0.9% |
| Dementia |
0.9% |
| Epilepsy |
0.8% |
|
| Weight Increased |
17.8% |
| Sudden Cardiac Death |
9.7% |
| Completed Suicide |
6.9% |
| Death |
6.0% |
| Pulmonary Embolism |
5.4% |
| Overdose |
4.7% |
| Psychotic Disorder |
4.6% |
| Tremor |
4.5% |
| Neutropenia |
4.4% |
| Tachycardia |
4.1% |
| Somnolence |
4.0% |
| Hypothermia |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Sedation |
3.6% |
| Toxicity To Various Agents |
3.4% |
| Product Substitution Issue |
2.9% |
| Suicide Attempt |
2.9% |
| Suicidal Ideation |
2.8% |
| Rhabdomyolysis |
2.5% |
| Thrombocytopenia |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
16.0% |
| Schizophrenia |
13.9% |
| Depression |
6.4% |
| Psychotic Disorder |
6.2% |
| Bipolar Disorder |
5.9% |
| Schizoaffective Disorder |
5.2% |
| Anxiety |
3.0% |
| Schizophrenia, Paranoid Type |
2.9% |
| Major Depression |
2.2% |
| Agitation |
2.1% |
| Insomnia |
2.1% |
| Mania |
1.8% |
| Self Injurious Behaviour |
1.5% |
| Bipolar I Disorder |
1.4% |
| Obsessive-compulsive Disorder |
1.2% |
| Hypertension |
1.2% |
| Feeling Abnormal |
1.1% |
| Frustration |
1.1% |
| Mental Disorder |
1.1% |
|
| Weight Increased |
19.3% |
| Completed Suicide |
9.9% |
| Toxicity To Various Agents |
7.2% |
| Respiratory Arrest |
5.8% |
| Somnolence |
4.9% |
| Tremor |
4.8% |
| Suicide Attempt |
4.5% |
| Tachycardia |
4.4% |
| Sedation |
4.2% |
| Overdose |
4.0% |
| Delirium |
3.9% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Vomiting |
3.5% |
| Psychotic Disorder |
3.4% |
| Dizziness |
3.2% |
| Hyperhidrosis |
2.9% |
| Hyponatraemia |
2.7% |
| Irritability |
2.7% |
| Rhabdomyolysis |
2.5% |
| Syncope |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.4% |
| Schizophrenia |
16.7% |
| Drug Use For Unknown Indication |
13.2% |
| Depression |
9.1% |
| Psychotic Disorder |
6.0% |
| Bipolar Disorder |
6.0% |
| Anxiety |
4.1% |
| Schizophrenia, Paranoid Type |
3.2% |
| Hiv Infection |
2.9% |
| Hypertension |
2.6% |
| Insomnia |
2.6% |
| Pain |
2.5% |
| Schizoaffective Disorder |
2.4% |
| Agitation |
2.3% |
| Affective Disorder |
1.8% |
| Depressed Mood |
1.6% |
| Mania |
1.3% |
| Sleep Disorder |
1.2% |
| Constipation |
1.1% |
| Nausea |
1.0% |
|
| White Blood Cell Count Decreased |
10.0% |
| Vomiting |
9.2% |
| Psychotic Disorder |
8.7% |
| White Blood Cell Count Increased |
7.9% |
| Weight Increased |
7.2% |
| Weight Decreased |
5.4% |
| Somnolence |
4.5% |
| Suicidal Ideation |
4.5% |
| Tremor |
4.2% |
| Neutropenia |
4.0% |
| Type 2 Diabetes Mellitus |
4.0% |
| Overdose |
3.7% |
| Pyrexia |
3.6% |
| Tachycardia |
3.6% |
| Thrombocytopenia |
3.6% |
| Tardive Dyskinesia |
3.5% |
| Withdrawal Syndrome |
3.5% |
| Suicide Attempt |
3.2% |
| Death |
3.0% |
| Pancreatitis |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
20.5% |
| Schizophrenia |
11.6% |
| Bipolar Disorder |
10.1% |
| Drug Use For Unknown Indication |
7.1% |
| Mental Disorder |
5.9% |
| Sedation |
5.3% |
| Depression |
4.5% |
| Schizophrenia, Catatonic Type |
4.2% |
| Psychotic Disorder |
3.6% |
| Suicide Attempt |
3.6% |
| Dementia |
3.3% |
| Hiv Infection |
3.0% |
| Agitation |
2.4% |
| Insomnia |
2.4% |
| Major Depression |
2.4% |
| Mania |
2.4% |
| Pyrexia |
2.4% |
| Hypertension |
2.1% |
| Anorexia Nervosa |
1.8% |
| Anxiety |
1.8% |
|
| Drug Interaction |
18.3% |
| Somnolence |
13.5% |
| Sedation |
9.6% |
| Oedema Peripheral |
6.7% |
| Hyponatraemia |
5.8% |
| Jaundice |
5.8% |
| Toxicity To Various Agents |
5.8% |
| Serotonin Syndrome |
4.8% |
| Grandiosity |
3.8% |
| Pancreatitis Acute |
3.8% |
| Electrocardiogram Qt Prolonged |
2.9% |
| Mental Status Changes |
2.9% |
| Neuroleptic Malignant Syndrome |
2.9% |
| Drug Ineffective |
1.9% |
| Encephalopathy |
1.9% |
| Hallucination |
1.9% |
| Mental Retardation |
1.9% |
| Miosis |
1.9% |
| Neutropenia |
1.9% |
| Off Label Use |
1.9% |
|
